Argenica Therapeutics Ltd (AU:AGN) has released an update.
Insignia Financial Ltd has emerged as a substantial shareholder in Argenica Therapeutics Limited with a 5.072% voting power after purchasing shares on the market over a four-month period, culminating on July 4, 2024. The holdings are registered under MLC Investments Ltd and IOOF Investment Services Ltd, with the largest single acquisition being over 4 million votes.
For further insights into AU:AGN stock, check out TipRanks’ Stock Analysis page.
